Ugawa T, Kakuta H, Moritani H, Matsuda K, Ishihara T, Yamaguchi M et al (2000) YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species
Side Effects and Safety Profile Like other GLP-1based therapies, Retatrutides side effects are largely gastrointestinal and dose-dependent but overall, it has shown a favorable safety profile in clinical trials so far
It's in the news, it's on social media, and it's at the center of every conversation about weight management
It leaves too much unanswered
Brain Volume and Vessel Presentation Brain volume and vessel presentation were proportional to the change in the brain or vessel surface area